Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DR-3355 injection in patients with peritonitis
jRCT2080221818Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of levofloxacin in Intra-abdominal infection (IAI) and peritonitis, sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
levofloxacin
03
Conditions
Intra-abdominal infection (IAI)peritonitis
Beyond the preview
Go deeper on jRCT2080221818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221818.